NGS-based assays & reagents

       NGS technologies have made high throughput and high sensitivity DNA sequencing possible. Millions of sequences are produced in a single next-generation sequencing process with a large amount of data in a short time. They are highly sensitive and accurate.

       LymphoTrack? assays kits are  lymphoma diagnosis and detection assay kits developed by Invivoscribe Inc. based on NGS technologies and are the only next-generation sequencing assay kits in BIOMED-2 protocols. These kits are designed specifically for commonly used next-generation analyzers Life Technologies Ion PGM? and Illumina MiSeq?, and iareapplicable to all-platform NGS.

       LymphoTrack? Assays significantly outperform the existing clonality assays available in the market. Ig/TCR gene analysis enables lymphoma rearrangements, somatic hypermutation and MRD detection at the same time. LymphoTrack? Assays have practical applications in a wide variety of fields including lymphoma diagnosis, genetic lineage identification, prognosis and MRD monitoring, etc.

Product list